Track topics on Twitter Track topics that are important to you
Saint Petersburg, FL, Nov. 10, 2017 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the cultivators of legal industrial hemp and marijuana, announces will be featuring its new exciting line of products at Marijuana Business Conference & Expo (MJBizCon) in Vegas.
"We are very excited to showcase our Grow.Droid product line at the show, in addition to our CogniteX Software and Fertigator, said John Verghese, COO. We've finalized improvements to the technology of our products and have incorporated several state-of-the-art technology applications to help cannabis growers dramatically streamline the grow process, record the grow and be able to repeat it for consistent high-quality pharma grade results."
The following Grow.Droid customizable solutions will be featured at the show:
An enhanced app of the CognetiX Software, from our GrowComm Division will also be demoed at the show. This app currently works with the IOS platform; an Android version is being developed and will be made available in early 2018.
Highlights of the software includes:
Fertigator, the first in the line of Artificial Intelligent (AI) grow systems for the medium to large scale growing facilities. The Fertigator.Droid is a fully engineered, industrial grade fertilizing and irrigation, (Fertigation) system that has a brain. Expanding on the intelligence found in the Grow.Droid grow systems, the Fertigator.Droid brings AI and analytics to the fertigation world.
Nuvus is committed to bring cutting edge technology to cannabis growers everywhere. The perfect blend of technology and human experience, we bring you the best in automation systems.
For more information on the grow-droid™ and other products offered by Nuvus, please contact us at 727-474-1810 or email@example.com.
About Nuvus Corp
Nuvus Corp (OTC PINK: HTCO), a Nevada Corporation, through its business units and subsidiaries, provides Advanced Controlled Environment Agriculture (CEA), Precise Cognitive Automation, Sophisticated Analytics, Artificial Intelligence (AI) Grow Systems, Modular Grow facilities, Power & Energy Services, Consulting Services and Financing for the cultivators and Medium to Large Scale Growing Facilities.
To request further information about HempTech, please email us at firstname.lastname@example.org, log onto our website at http://www.nuvuscorp.com or visit us at our Facebook page https://www.facebook.com/hemptechcorp or on Twitter @nuvuscorp.
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
CONTACT INFORMATION Media Contact Nuvus Corp. Http://www.nuvuscorp.com email@example.com Phone - (727) 474-1810 Twitter - @ nuvuscorp Facebook - hemptechcorpNEXT ARTICLE
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...